XML 47 R20.htm IDEA: XBRL DOCUMENT
v3.20.1

Earnings Per Share | 3 Months Ended
--- | ---
Mar. 31, 2020
Earnings Per Share [Abstract] |
Earnings Per Share | Earnings Per Share Basic earnings per share is calculated using the weighted average number of shares of the Company’s common stock issued and outstanding during a certain period, and is calculated by dividing net income attributable to Apollo Medical Holdings, Inc. by the weighted average number of shares of the Company’s common stock issued and outstanding during such period. Diluted earnings per share is calculated using the weighted average number of shares of common stock and potentially dilutive shares of common stock outstanding during the period, using the as-if converted method for secured convertible notes, preferred stock, and the treasury stock method for options and common stock warrants. As of March 31, 2020 and December 31, 2019 APC held 17,307,214 and 17,290,317 shares of ApolloMed’s common stock, respectively, which are treated as treasury shares for accounting purposes and not included in the number of shares of common stock outstanding used to calculate earnings per share. Below is a summary of the earnings per share computations:
Three Months Ended March 31, |  | 2020 |  | 2019
Earnings per share – basic |  | $ | 0.11 |  |  | $ | — |
Earnings per share – diluted |  | $ | 0.11 |  |  | $ | — |
Weighted average shares of common stock outstanding – basic |  | 36,010,268 |  |  | 34,496,622 |
Weighted average shares of common stock outstanding – diluted |  | 37,439,099 |  |  | 38,074,174 |
Below is a summary of the shares included in the diluted earnings per share computations:
Three Months Ended March 31, |  | 2020 |  | 2019
Weighted average shares of common stock outstanding – basic |  | 36,010,268 |  |  | 34,496,622 |
10% shares held back pursuant to indemnification clause |  | — |  |  | 1,519,805 |
Stock options |  | 185,830 |  |  | 455,381 |
Warrants |  | 1,207,445 |  |  | 1,602,366 |
Restricted stock units |  | 35,556 |  |  | — |
Weighted average shares of common stock outstanding – diluted |  | 37,439,099 |  |  | 38,074,174 |

X
- References No definition available. + Details
Name: | us-gaap_EarningsPerShareAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for earnings per share. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -URI http://asc.fasb.org/topic&trid=2144383 + Details
Name: | us-gaap_EarningsPerShareTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration